Enhancing Capital LLC Purchases New Position in Colgate-Palmolive (NYSE:CL)

Enhancing Capital LLC acquired a new position in Colgate-Palmolive (NYSE:CL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,000 shares of the company's stock, valued at approximately $364,000.

A number of other institutional investors and hedge funds have also modified their holdings of CL. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the 4th quarter valued at $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive during the 4th quarter valued at $32,000. Finally, Wintrust Investments LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at $33,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

NYSE:CL traded up $0.02 during mid-day trading on Friday, reaching $90.30. 8,950,637 shares of the company were exchanged, compared to its average volume of 4,226,202. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a fifty day moving average of $89.33 and a 200 day moving average of $94.18. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market cap of $73.28 billion, a PE ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the company posted $0.87 EPS. On average, research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive declared that its board has initiated a share repurchase plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 6.8% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive's dividend payout ratio is presently 56.82%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Friday, March 14th. Raymond James restated an "outperform" rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday, January 17th. Finally, Royal Bank of Canada restated a "sector perform" rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.